Search

Your search keyword '"Martignetti A"' showing total 1,340 results

Search Constraints

Start Over You searched for: Author "Martignetti A" Remove constraint Author: "Martignetti A"
1,340 results on '"Martignetti A"'

Search Results

5. An integrated empirical and computational study to decipher help-seeking behaviors and vocal stigma

6. From CFTR to a CF signalling network: a systems biology approach to study Cystic Fibrosis

7. Barriers to primary care among immigrants and refugees in Peterborough, Ontario: a qualitative study of provider perspectives

8. Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

9. Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: The POST trial

10. Measuring Lessons Learned from Durham Region’s Community Hub Model During COVID-19: A Support Solution for Individuals Experiencing Homelessness and Other At-Risk Populations

11. EM-Act: A Modular Series Elastic Actuator for Dynamic Robots

12. Representation and quantification of module activity from omics data with rROMA

13. Bone targeting agents, but not radiation therapy, improves survival in patients with bone metastases from advanced urothelial carcinoma receiving pembrolizumab: results from the ARON-2 study

14. Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

27. MiREx: mRNA levels prediction from gene sequence and miRNA target knowledge

28. Mutations in cancer-relevant genes are ubiquitous in histologically normal endometrial tissue

29. Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation

31. Integrated microRNA and proteome analysis of cancer datasets with MoPC.

33. Challenges of implementing safer supply programs in Canada during the COVID-19 pandemic: A qualitative analysis

34. Proteogenomic insights suggest druggable pathways in endometrial carcinoma

36. ClustMMRA v2: A Scalable Computational Pipeline for the Identification of MicroRNA Clusters Acting Cooperatively on Tumor Molecular Subgroups

37. Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy

38. Identification of microRNA clusters cooperatively acting on Epithelial to Mesenchymal Transition in Triple Negative Breast Cancer

42. Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trial

43. Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients

44. TGFβ pathway is required for viable gestation of Fanconi anemia embryos.

49. Wearable Neck Surface Accelerometers for Occupational Vocal Health Monitoring: Instrument and Analysis Validation Study

50. Efficient and Explainable Deep Neural Networks for Airway Symptom Detection in Support of Wearable Health Technology

Catalog

Books, media, physical & digital resources